 |
 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Delayed-Onset Heparin-Induced Thrombocytopenia
5 February 2002 | Volume 136 Issue 3 | Page I34
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine.
The summary below is from the full report titled "Delayed-Onset Heparin-Induced Thrombocytopenia." It is in the 5 February 2002 issue of Annals of Internal Medicine (volume 136, pages 210-215). The authors are L Rice, WK Attisha, A Drexler, and JL Francis.
What is the problem and what is known about it so far?
Heparin is a blood thinner that prevents or treats abnormal blood clots in the veins. It also causes several complications. One serious complication is an "autoimmune" reaction. In this complication, heparin molecules combine with a body protein called platelet factor 4. This leads to the production of antibodies that attack blood platelets, which are necessary for forming blood clots. The damaged platelets may trigger uncontrolled clot formation. This life-threatening situation, known as heparin-induced thrombocytopenia, occurs in 3% of heparin-treated patients. Although heparin-induced thrombocytopenia usually occurs within 5 to 12 days after starting heparin therapy, doctors are starting to realize that heparin-induced thrombocytopenia may begin or may be recognized more than 12 days after the start of heparin therapy (delayed-onset heparin-induced thrombocytopenia).
Why did the researchers do this particular study?
To prove that delayed-onset heparin-induced thrombocytopenia actually happens and to describe the illness.
Who was studied?
14 patients with heparin-induced thrombocytopenia who were treated at one of three U.S. hospitals between 1997 and 2000.
How was the study done?
All 14 patients had tests for heparin antibodies. The authors reported the date on which the disease began after the patients first took heparin and what the patients experienced.
What did the researchers find?
Thirteen of the 14 patients had been discharged from the hospital in satisfactory condition after receiving heparin therapy. Within a few weeks, they developed symptoms and returned to the hospital. Test results showed blood clots in the veins of 12 patients and in the arteries of 4 patients (2 patients had clots in both types of blood vessels). Doctors gave heparin to 11 patients to treat the blood clots because in each case, the doctors did not realize that the patient had heparin-induced thrombocytopenia. After receiving heparin therapy, the number of platelets decreased dramatically in all patients. When the doctors found antibodies to heparin, they made the correct diagnosis, stopped the heparin therapy, and started other treatments.
What were the limitations of the study?
The incidence of delayed-onset heparin-induced thrombocytopenia could not be determined because the authors did not prospectively evaluate all patients for possible adverse platelet reactions to heparin at their hospitals between 1997 and 2000.
What are the implications of the study?
When blood clots occur within several weeks after heparin treatment, doctors should suspect that antibodies against heparin are causing the problem. Treatment with heparin is dangerous (or even lethal) in patients with delayed-onset heparin-induced thrombocytopenia.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  J. G. Kelton and T. E. Warkentin Heparin-induced thrombocytopenia: a historical perspective Blood, October 1, 2008; 112(7): 2607 - 2616. [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Warkentin, A. Greinacher, A. Koster, and A. M. Lincoff Treatment and Prevention of Heparin-Induced Thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 340S - 380S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Levy, K. A. Tanaka, and M. J. Hursting Reducing Thrombotic Complications in the Perioperative Setting: An Update on Heparin-Induced Thrombocytopenia Anesth. Analg., September 1, 2007; 105(3): 570 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, J.-P. Bassand, C. W. Hamm, D. Ardissino, E. Boersma, A. Budaj, F. Fernandez-Aviles, K. A.A. Fox, D. Hasdai, E. M. Ohman, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology Eur. Heart J., July 1, 2007; 28(13): 1598 - 1660. [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Warkentin, B. T. Maurer, R. H. Aster, J. Soffer, J. Patel, and R. Saltzman Heparin-Induced Thrombocytopenia Associated with Fondaparinux N. Engl. J. Med., June 21, 2007; 356(25): 2653 - 2655. [Full Text] [PDF]
|
|
|
|
|
|
T. E. Warkentin and J. W. Eikelboom Who Is (Still) Getting HIT? Chest, June 1, 2007; 131(6): 1620 - 1622. [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Cooney Heparin-induced thrombocytopenia: advances in diagnosis and treatment. Crit. Care Nurse, December 1, 2006; 26(6): 30 - 36. [Full Text] [PDF]
|
|
|
|
|
|
T. E. Warkentin, J.-A. I. Sheppard, C. S. Sigouin, T. Kohlmann, P. Eichler, and A. Greinacher Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia Blood, November 1, 2006; 108(9): 2937 - 2941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Levine, D. McCollum, and M. J. Hursting How frequently is venous thromboembolism in heparin-treated patients associated with heparin-induced thrombocytopenia? Chest, September 1, 2006; 130(3): 681 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Arepally and T. L. Ortel Heparin-Induced Thrombocytopenia N. Engl. J. Med., August 24, 2006; 355(8): 809 - 817. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Piazza and S. Z. Goldhaber Acute Pulmonary Embolism: Part II: Treatment and Prophylaxis Circulation, July 18, 2006; 114(3): e42 - e47. [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Jackson, W. J. Neilson, M. Lary, P. Baay, K. Web, and G. P. Clagett Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis After Intraoperative Heparin Anticoagulation: Four Case Reports Vascular and Endovascular Surgery, January 1, 2006; 40(1): 67 - 70. [Abstract] [PDF]
|
|
|
|
 |
|
 T. E. Warkentin Think of HIT Hematology, January 1, 2006; 2006(1): 408 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Prandoni, S. Siragusa, B. Girolami, F. Fabris, and for the BELZONI Investigators Group The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study Blood, November 1, 2005; 106(9): 3049 - 3054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I.-K. Jang and M. J. Hursting When Heparins Promote Thrombosis: Review of Heparin-Induced Thrombocytopenia Circulation, May 24, 2005; 111(20): 2671 - 2683. [Full Text] [PDF]
|
|
|
|
|
|
R. L. Levine Finding Haystacks Full of Needles: From Opus to Osler Chest, May 1, 2005; 127(5): 1488 - 1490. [Full Text] [PDF]
|
|
|
|
|
|
L. Rice Cases of Heparin-Induced Thrombocytopenia Elucidate the Syndrome Chest, February 1, 2005; 127(2_suppl): 21S - 26S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Bartholomew Transition to an Oral Anticoagulant in Patients With Heparin-Induced Thrombocytopenia Chest, February 1, 2005; 127(2_suppl): 27S - 34S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Warkentin New Approaches to the Diagnosis of Heparin-Induced Thrombocytopenia Chest, February 1, 2005; 127(2_suppl): 35S - 45S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Rice Heparin-Induced Thrombocytopenia: Myths and Misconceptions (That Will Cause Trouble for You and Your Patient) Arch Intern Med, October 11, 2004; 164(18): 1961 - 1964. [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Smythe, W. E. Dager, and N. M. Patel Managing Complications of Anticoagulant Therapy Journal of Pharmacy Practice, October 1, 2004; 17(5): 327 - 346. [Abstract] [PDF]
|
|
|
|
|
|
T. E. Warkentin and A. Greinacher Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 311S - 337S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Mosen, C. G. Elliott, M. J. Egger, M. Mundorff, J. Hopkins, R. Patterson, and R. M. Gardner The Effect of a Computerized Reminder System on the Prevention of Postoperative Venous Thromboembolism Chest, May 1, 2004; 125(5): 1635 - 1641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Srinivasan, L. Rice, J. R. Bartholomew, C. Rangaswamy, L. La Perna, J. E. Thompson, S. Murphy, and K. R. Baker Warfarin-Induced Skin Necrosis and Venous Limb Gangrene in the Setting of Heparin-Induced Thrombocytopenia Arch Intern Med, January 12, 2004; 164(1): 66 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. De Palma Delayed-Onset Heparin-Induced Thrombocytopenia Ann Intern Med, November 4, 2003; 139(9): 790 - 790. [Full Text] [PDF]
|
|
|
|
|
|
R. Kane Delayed-Onset Heparin-Induced Thrombocytopenia Ann Intern Med, November 4, 2003; 139(9): 790 - 790. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Suzuki, S. Sakamoto, T. Okada, M. Matsuo, A. Saitoh, and T. Matsuo Acute Myocardial Infarction Caused by Delayed Heparin-Induced Thrombocytopenia and Acute Immunoreaction due to Re-exposure to Heparin in a Systemic Lupus Erythematosus Patient with HIT Antibodies Clinical and Applied Thrombosis/Hemostasis, October 1, 2003; 9(4): 341 - 346. [Abstract] [PDF]
|
|
|
|
|
|
B. Girolami, P. Prandoni, P. M. Stefani, C. Tanduo, P. Sabbion, P. Eichler, R. Ramon, G. Baggio, F. Fabris, and A. Girolami The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study Blood, April 15, 2003; 101(8): 2955 - 2959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Warkentin and R. A. Bernstein Delayed-Onset Heparin-Induced Thrombocytopenia and Cerebral Thrombosis after a Single Administration of Unfractionated Heparin N. Engl. J. Med., March 13, 2003; 348(11): 1067 - 1069. [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Warkentin Pork or beef? Ann. Thorac. Surg., January 1, 2003; 75(1): 15 - 16. [Full Text] [PDF]
|
|
|
|
|
|
J. L. Francis, G. J. Palmer III, R. Moroose, and A. Drexler Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery Ann. Thorac. Surg., January 1, 2003; 75(1): 17 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. U. Jones, J. B. Muhlestein, K. W. Jones, T. L. Bair, F. Lavasani, M. Sohrevardi, B. D. Horne, D. Doty, and D. L. Lappe Preoperative Use of Enoxaparin Compared With Unfractionated Heparin Increases the Incidence of Re-Exploration for Postoperative Bleeding After Open-Heart Surgery in Patients Who Present With an Acute Coronary Syndrome: Clinical Investigation and Reports Circulation, September 24, 2002; 106(12_suppl_1): I-19 - I-22. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Heparin-Induced Thrombocytopenia as a Cause of Thromboembolism in Outpatients Journal Watch Cardiology, April 19, 2002; 2002(419): 4 - 4. [Full Text]
|
|
|
|
 |
|
 Heparin-Induced Thrombocytopenia as a Cause of Thromboembolism in Outpatients Journal Watch (General), March 8, 2002; 2002(308): 2 - 2. [Full Text]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
